Expression of proto-oncogene products during drug-induced differentiation of a neuroblastoma cell line SK-N-DZ

Acta Neuropathol. 1989;79(2):217-21. doi: 10.1007/BF00294382.

Abstract

Four human neuroblastoma cell lines exhibited differences in their ability to differentiate into neuron-like cells in response to three different treatments, serum deprivation, or additions of dibutyryl cyclic-AMP or retinoic acid. Expression of N-myc gene product was reduced in neuroblastoma cell line SK-N-DZ differentiated by retinoic acid as compared with untreated cells. On the contrary, expression of c-src gene product, pp60c-src, was considerably enhanced in differentiated SK-N-DZ cells. Tyrosine phosphorylation of several cellular proteins was found to be enhanced in differentiated cells. Alteration in expression of these proto-oncogene products might be important in the differentiation of neuroblastoma cells into neuron-like cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bucladesine / pharmacology*
  • Cell Differentiation / drug effects
  • Cell Line
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Immunohistochemistry
  • Neuroblastoma*
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins c-myc
  • Proto-Oncogene Proteins pp60(c-src)
  • Tretinoin / metabolism*
  • Tumor Cells, Cultured / cytology
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism*

Substances

  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-myc
  • Tretinoin
  • Bucladesine
  • Proto-Oncogene Proteins pp60(c-src)